
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Director Emerald Fennell explains why "Wuthering Heights" has quotation marks around the title - 2
The most effective method to Guarantee Scholastic Honesty in Web-based Degrees - 3
The Best Cell phone Brands for Tech Aficionados - 4
Share your pick for the riding area that characterizes your surf undertakings! - 5
These Cities Led Global Jet-Setting In 2025, According To New Data
Inconceivable Spots To Stargaze All over The Planet
Social Skylines d: A Survey of \Inside and out Social Experiences\ Language Learning Book
Washington resident contracts bird flu, first human case in U.S. since February
A 'Stranger Things' documentary covering the final season is on its way: Watch the trailer
Hundreds show fascist salute at rally in Rome in annual ritual
UNICEF: More than 100 children killed in Gaza since ceasefire
Kiefer Sutherland arrested after allegedly assaulting a ride-share driver in L.A.
Israel approves 19 new West Bank settlements in major annexation push
Sa'ar warns German delegation: 'A Palestinian state would be a Hamas terror state'












